E³ - Advanced Course: Hybrid Imaging

E³ 1819 - Hybrid imaging in prostate cancer

March 1, 09:30 - 11:00 CET

5 min
Chairpersons' introduction
Matthias Eiber, Vaterstetten / Germany
Tara Barwick, London / United Kingdom
23 min
PET/MR in prostate cancer incl. local staging
Maria Picchio, Milan / Italy
  1. To identify how PSMA PET/MRI improves the diagnostic accuracy for localisation of PCA, especially in patients with PIRADS 3, and the local staging with regard to SVI in comparison to mpMRI.
  2. To evaluate the improvement in the detection and characterisation of primary PCA with the simultaneous acquisition of PET images using PSMA and mp-MRI, which provides metabolic, structural, and functional information of PCA status in a single session of the whole body.
23 min
Theranostics in prostate cancer
Amy Eccles, London / United Kingdom
  1. To name different tracers used in the assessment of patients considered for molecular radiotherapy treatments for prostate cancer.
  2. To understand functional imaging in patient selection for molecular radiotherapy in prostate cancer.
  3. To understand functional imaging in response to molecular radiotherapy.
23 min
Clinical cases: whole-body PSMA PET/CT incl. pitfalls
Tara Barwick, London / United Kingdom
  1. To be familiar with the different PSMA PET radiotracers.
  2. To understand the strengths and weaknesses of PSMA imaging.
  3. To review clinical cases, focussing on potential pitfalls.
16 min
Panel discussion: Rockstar PSMA: what remains to be accomplished?